Gamma interferon as an antifibrosis agent in skeletal muscle

Journal of Orthopaedic Research

Volumn 21, Issue 5, 2003, Pages 798-804

  Foster, William ^a   Li, Yong ^a   Usas, Arvydas ^a   Somogyi, George ^a   Huard, Johnny ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Fibrosis; Gamma interferon; Muscle injuries; Muscle regeneration; Transforming growth factor 1

Indexed keywords

JOINTS (ANATOMY); MUSCLE; PROTEINS;

ANTIFIBROSIS;

ORTHOPEDICS;

ALPHA ACTIN; GAMMA INTERFERON; MUSCLE PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENCY; FAST MUSCLE; FIBROBLAST; GROWTH RATE; HEALING; IN VITRO STUDY; IN VIVO STUDY; LACERATION; MOUSE; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE REGENERATION; MUSCLE TETANIC CONTRACTION; MYOFIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SMOOTH MUSCLE;

EID: 0042889170     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-0266(03)00059-7     Document Type: Article

References (36)

1. Baroni G, D'Ambrosio L, Curto P, et al. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 1996;23:1189-99.
2. Border W, Noble N. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-92.
3. Brocks L, Jap PH, Ramaekers FC, et al. Vimentin and desmin expression in degenerating and regenerating dystrophic murine muscles. Virchows Arch B Cell Pathol Incl Mol Pathol 1991; 61:89-96.
4. Croisier J, Forthomme B, Namurois M, et al. Hamstring muscle strain recurrence and strength performance disorders. Am J Sports Med 2002;30:199-203.
5. Friedman S. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275:2247-50.
6. Fukushima K, Badlani N, Usas A, et al. The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med 2001;29:394-402.
7. Garrett Jr W, Seaber AV, Boswick J, et al. Recovery of skeletal muscle after laceration and repair. J Hand Surg 1984; 9A:683-92.
8. Garrett W. Muscle strain injuries. Am J Sports Med 1996;24:S2-8.
9. Ghosh A, Yan W, Mori Y, et al. Antagonistic regulation of type I collagen gene expression by interferon-γ and transforming growth factor-β. J Biol Chem 2001;276:11041-8.
10. Grounds M. Muscle regeneration: molecular aspects and therapeutic implications. Curr Opin Neurol 1999;12:535-43.
11. Huard J, Li Y, Fu F. Muscle injuries and repair: current trends in research. J Bone Joint Surg Am 2002;84-A:822-32.
12. Hunzelmann N, Anders S, Fierlbeck G, et al. Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma. J Am Acad Dermatol 1997; 36:433-5.
13. Jarvinen T, Kaarianen M, Jarvinen M, et al. Muscle strain injuries. Curr Opin Rheumatol 2000;12:155-61.
14. Kasemkijwattana C, Menetrey J, Bosch P, et al. Use of growth factors to improve muscle healing after strain injury. Clin Orthop 2000;370:272-85.
15. Kasemkijwattana C, Menetrey J, Day C, et al. Biologic intervention in muscle healing and regeneration. Sports Med Arthrosc Rev 1998;6:95-102.
16. Kasemkijwattana C, Menetrey J, Somogyi G, et al. Development of approaches to improve the healing following muscle contusion. Cell Transplant 1998;7:585-98.
17. Kellett J. Acute soft tissue injuries - a review of the literature. Med Sci Sports Exerc 1986;18:489-500.
18. Li Y, Cummins J, Huard J. Muscle injury and repair. Curr Opin Orthop 2001;12:409-15.
19. Li Y, Han B, Li K, et al. TGF-beta 1 inhibits HLA-DR and beta 2-microglobulin expression in HeLa cells induced with γ-IFN. Transplant Proc 1999;31:2143-5.
20. Li Y, Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 2002; 161:895-907.
21. Menetrey J, Kasemkijwattana C, Day C, et al. Growth factors improve muscle healing in vivo. J Bone Joint Surg Br 2000;82-B:131-7.
22. Menetrey J, Kasemkijwattana, C, Fu F, et al. Suturing versus immobilization of a muscle laceration. Am J Sports Med 1999; 27:222-9.
23. Obremsky W, Seaber A, Ribbeck B, Garrett W. Biomechanical and histologic assessment of a controlled muscle strain injury treated with piroxicam. Am J Sports Med 1994;22:558-61.
24. Oldroyd S, Thomas G, Gabbiani G, et al. Interferon-γ inhibits experimental renal fibrosis. Kidney Int 1999;56:2116-27.
25. Orchard J, Best T. The management of muscle strain injuries: an early return versus the risk of recurrence. Clin J Sport Med 2002;12:3-5.
26. Phan S, Zhang K, Zhang H, Gharaee-Kermani M. The myofibroblast as an inflammatory cell in pulmonary fibrosis. Curr Top Pathol 1999;93:173-82.
27. Qu Z, Balkir L, Van Deutekom J, et al. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 1998;142:1257-67.
28. Sappino A, Schurch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990;63:144-61.
29. Serini G, Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res 1999;250:273-83.
30. Striz I, Mio T, Adachi Y, et al. Effects of interferons alpha and gamma on cytokine production and phenotypic pattern of human bronchial epithelial cells. Int J Immunopharmacol 2000;22:573-85.
31. Thorsson O, Rantanen J, Hurme T, Kalimo H. Effects of nonsteroidal anti-inflammatory medication on satellite cell proliferation during muscle regeneration. Am J Sports Med 1998; 26:172-6.
32. Ulloa L, Doody J, Massague J. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway. Nature 1999;397:710-3.
33. Vaughan M, Howard E, Tomasek J. Transforming growth factor-β1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res 2000;257:180-9.
34. Verall G, Slavotinek J, Barnes P, et al. Clinical risk factors for hamstring muscle strain injury: a prospective study with correlation of injury by magnetic resonance imaging. Br J Sports Med 2001;35:435-9.
35. Yokozeki M, Baba Y, Shimokawa H, et al. Interferon-γ inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor-β1 in vitro. FEBS Lett 1999; 442:61-4.
36. Zhang Li, Mi J, Yu Yizhi, et al. IFN-γ gene therapy by intrasplenic hepatocyte transplantation: a novel strategy for reversing hepatic fibrosis in schistosoma japonicum-infected mice. Parasite Immunol 2001;23:11-7.